PIOGLITAZONE Side Effects

6994552-5 | Blood Glucose Increased, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease
on Sep 15, 2010 Male patient from UNITED STATES , 71 years of age, weighting 260.1 lb, was diagnosed with cardiac failure congestive and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, cardiac failure congestive, chronic obstructive pulmonary disease. Pioglitazone dosage: 1 Tab Every Day Po. Patient was hospitalized.

6958371-8 | Abdominal Pain, Diarrhoea, Hepatic Enzyme Increased, Nausea, Pancreatitis Relapsing
Patient was taking Pioglitazone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, hepatic enzyme increased, nausea (What is nausea?), pancreatitis relapsing on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, weighting 140.0 lb, . Pioglitazone dosage: 1 Daily Mouth. During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), CREON (View Creon Review and Creon Label ), RESTORIL (View Restoril Review and Restoril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6925888-1 | Oedema, Weight Increased
Adverse event was reported on Aug 13, 2010 by a Male patient taking Pioglitazone (View Usage) (Dosage: 30 Mg Every Day Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 85 years of age, weighting 233.7 lb, After Pioglitazone was administered, patient had the following side effects: oedema, weight increased.

6822080-6 | Cardiac Failure Congestive, Condition Aggravated
on Jul 06, 2010 Male patient from UNITED STATES , 62 years of age, weighting 215.0 lb, was diagnosed with diabetes mellitus and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, condition aggravated. Pioglitazone dosage: 15 Mg Every Day Po. Patient was hospitalized.


6815251-6 | Cough, Diarrhoea, Pruritus, Pyrexia, Rash, Urticaria
on Jul 01, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Pioglitazone (View Usage). Patient had the following side effects: cough, diarrhoea, pruritus, pyrexia, rash (What is rash?), urticaria. Pioglitazone dosage: 15 Mg Every Day Po. During the same period patient was treated with DRONEDARONE HCL (400 Mg Bid Po) (View Dronedarone Hcl Review and Dronedarone Hcl Label ).

6726090-9 | Bladder Transitional Cell Carcinoma
Patient was taking Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: bladder transitional cell carcinoma on May 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, was diagnosed with diabetes mellitus and. Pioglitazone dosage: (30 Mg), Oral. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6722841-8 | Abdominal Pain, Hyperglycaemia, Vomiting
Adverse event was reported on May 12, 2010 by a Male patient taking Pioglitazone (View Usage) (Dosage: 1 Daily By Mouth) . Location: UNITED STATES , 46 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), hyperglycaemia, vomiting. During the same period patient was treated with RESTORIL (View Restoril Review and Restoril Label ), LORTAB (View Lortab Review and Lortab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), MEGACE (View Megace Review and Megace Label ). Patient was hospitalized.

6709424-0 | Abdominal Pain, Nausea
on May 03, 2010 Male patient from UNITED STATES , 46 years of age, weighting 137.3 lb, was treated with Pioglitazone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?). Pioglitazone dosage: 1 Daily By Mouth. During the same period patient was treated with RESTORIL (View Restoril Review and Restoril Label ), LORTAB (View Lortab Review and Lortab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6709423-9 | Gastritis, Nausea, Pancreatitis
on May 03, 2010 Male patient from UNITED STATES , 46 years of age, weighting 137.3 lb, was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: gastritis, nausea (What is nausea?), pancreatitis. Pioglitazone dosage: 1 Daily By Mouth. Patient was hospitalized.

6678139-X | Lobar Pneumonia, Sepsis
Patient was taking Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: lobar pneumonia, sepsis (What is sepsis?) on Apr 09, 2010 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 138.9 lb, . Pioglitazone dosage: 1 Daily By Mouth. During the same period patient was treated with HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), COMPAZINE (View Compazine Review and Compazine Label ), SOMA (View Soma Review and Soma Label ), NORCOL (View Norcol Review and Norcol Label ). Patient was hospitalized.

6631419-6 | Condition Aggravated, Nephrolithiasis, Orthostatic Hypotension, Vertigo
Adverse event was reported on Mar 11, 2010 by a Female patient taking Pioglitazone (View Usage) (Dosage: 30 1 Po) was diagnosed with pancreatitis chronic and. Location: UNITED STATES , 52 years of age, weighting 237.0 lb, Patient had the following side effects: condition aggravated, nephrolithiasis, orthostatic hypotension, vertigo. Patient was hospitalized.

6608693-5 | Liver Function Test Abnormal
on Feb 24, 2010 Male patient from UNITED STATES , 30 years of age, weighting 203.0 lb, was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: liver function test abnormal. Pioglitazone dosage: 15mg Po. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANGUS (View Langus Review and Langus Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZYDIS (View Zydis Review and Zydis Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6593939-2 | Cardiac Failure
on Feb 18, 2010 Male patient from UNITED STATES , 62 years of age, weighting 196.2 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Pioglitazone dosage: 30 Mg Every Day Po. Patient was hospitalized.

6573564-X | Weight Increased
Patient was taking Pioglitazone (View Usage). Patient had the following side effects: weight increased on Feb 04, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 244.0 lb, was diagnosed with diabetes mellitus and. Pioglitazone dosage: 30 Mg Every Day Po.

6524245-X | Cardiac Failure Congestive
Adverse event was reported on Dec 30, 2009 by a Male patient taking Pioglitazone (View Usage) (Dosage: 15 Mg Every Day Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 56 years of age, weighting 260.4 lb, After Pioglitazone was administered, patient had the following side effects: cardiac failure congestive. Patient was hospitalized.

6426404-3 | Cardiac Failure Congestive, Condition Aggravated, Disease Recurrence, Hypotension, Ischaemia
on Nov 03, 2009 Male patient from UNITED STATES , 69 years of age, was diagnosed with diabetes mellitus and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, condition aggravated, disease recurrence, hypotension, ischaemia. Pioglitazone dosage: 45 Mg Every Day Po. Patient was hospitalized.

6405882-X | Abnormal Behaviour, Aggression, Alcoholism, Condition Aggravated, Delusion, Personality Change, Physical Abuse
on Oct 16, 2009 Male patient from UNITED STATES , 53 years of age, weighting 160.0 lb, was treated with Pioglitazone (View Usage). Patient had the following side effects: abnormal behaviour, aggression, alcoholism (What is alcoholism?), condition aggravated, delusion, personality change, physical abuse. Pioglitazone dosage: . During the same period patient was treated with PROLIXIN (10 Mg Five Times Per Day) (View Prolixin Review and Prolixin Label ).

6328589-6 | Dyspnoea Exertional, Oedema Peripheral
Patient was taking Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: dyspnoea exertional, oedema peripheral on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with diabetes mellitus and. Pioglitazone dosage: 30 Mg Every Day Po.

6307597-5 | Weight Increased
Adverse event was reported on Aug 12, 2009 by a Male patient taking Pioglitazone (View Usage) (Dosage: 45 Mg Everyday Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 78 years of age, weighting 102.5 lb, Patient experienced the following unwanted or unexpected effects: weight increased.

6290863-X | Cardiac Failure Congestive
on Jul 28, 2009 Male patient from UNITED STATES , 73 years of age, weighting 184.1 lb, was diagnosed with diabetes mellitus and was treated with Pioglitazone (View Usage). Patient had the following side effects: cardiac failure congestive. Pioglitazone dosage: 30mg, Every Day, Po.

6215090-3 | Arthralgia
on May 22, 2009 Male patient from UNITED KINGDOM , 61 years of age, weighting 249.1 lb, was diagnosed with diabetes mellitus, myocardial ischaemia, hypercholesterolaemia, benign prostatic hyperplasia and was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: arthralgia. Pioglitazone dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), AAG (View Aag Review and Aag Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ).

6184002-3 | Chromaturia, Impaired Driving Ability, Vision Blurred
Patient was taking Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia, impaired driving ability, vision blurred on May 06, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 221.6 lb, was diagnosed with diabetes mellitus, cardiovascular disorder, surgery (What is surgery?) and. Pioglitazone dosage: 15 Mg Every Day Po. During the same period patient was treated with ASPIRIN (325 Mg Every Day Po) (View Aspirin Review and Aspirin Label ).

6168835-5 | Chest Pain, Hypoaesthesia, Paraesthesia, Transient Ischaemic Attack
Adverse event was reported on Apr 24, 2009 by a Female patient taking Pioglitazone (View Usage) (Dosage: 45 Mg. P.o Q.d) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 182.0 lb, Patient had the following side effects: chest pain (What is chest pain?), hypoaesthesia, paraesthesia, transient ischaemic attack. During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), LIBRIUM (View Librium Review and Librium Label ), BENTYL (View Bentyl Review and Bentyl Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), HIDROLOROTHIAZIDE (View Hidrolorothiazide Review and Hidrolorothiazide Label ). Patient was hospitalized.

6144891-5 | Back Pain, Blood Amylase Increased, Decreased Appetite, Fatigue, Lipase Increased
on Apr 02, 2009 Male patient from UNITED STATES , 60 years of age, weighting 170.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: back pain (What is back pain?), blood amylase increased, decreased appetite, fatigue, lipase increased. Pioglitazone dosage: 1 Tablet Daily Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LANTUS (View Lantus Review and Lantus Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOCOR (View Zocor Review and Zocor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6105243-7 | Oedema Peripheral
on Mar 04, 2009 Male patient from UNITED STATES , 76 years of age, weighting 284.0 lb, was diagnosed with diabetes mellitus and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Pioglitazone dosage: 30 Mg Every Day Po.

6064024-3 | Cardiac Failure, Right Ventricular Failure, Weight Increased
Patient was taking Pioglitazone (View Usage). Patient had the following side effects: cardiac failure, right ventricular failure, weight increased on Feb 03, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with diabetes mellitus and. Pioglitazone dosage: 30 Mg Every Day Po. Patient was hospitalized.

5796799-2 | Abortion Spontaneous, Pregnancy
Adverse event was reported on Jun 30, 2008 by a Female patient taking Pioglitazone (View Usage) (Dosage: 1 Tablet) . Location: UNITED STATES , weighting 166.0 lb, After Pioglitazone was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5763959-6 | Abdominal Pain, Asthenia, Bronchitis, Chills, Dysuria, Fatigue, Hepatitis, Hyperbilirubinaemia, Hypokalaemia
on Jun 02, 2008 Male patient from UNITED STATES , 49 years of age, weighting 262.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, bronchitis (What is bronchitis?), chills, dysuria, fatigue, hepatitis (What is hepatitis?), hyperbilirubinaemia, hypokalaemia. Pioglitazone dosage: 1 Tablet Daily Oral/previous 6 Months. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), DOXYLAMINE (View Doxylamine Review and Doxylamine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

5663476-8 | Bladder Disorder, Haematuria, Renal Cyst
on Feb 26, 2008 Male patient from UNITED STATES , 69 years of age, weighting 260.0 lb, was diagnosed with cardiovascular event prophylaxis and was treated with Pioglitazone (View Usage). Patient had the following side effects: bladder disorder, haematuria, renal cyst. Pioglitazone dosage: 1 In 1 D, Per Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

5583159-2 | Cholangitis, Oedema Peripheral
Patient was taking Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: cholangitis, oedema peripheral on Jan 03, 2008 from UNITED STATES Additional patient health information: Male patient , 80 years of age, was diagnosed with diabetes mellitus and. Pioglitazone dosage: . Patient was hospitalized.

5573622-2 | Benign Prostatic Hyperplasia, Blood Thyroid Stimulating Hormone Increased, Cardiac Arrest, Catheterisation Cardiac, Coronary Artery Occlusion, Ejection Fraction Decreased, Nausea, Nocturia
Adverse event was reported on Dec 13, 2007 by a Male patient taking Pioglitazone (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: benign prostatic hyperplasia, blood thyroid stimulating hormone increased, cardiac arrest (What is cardiac arrest?), catheterisation cardiac, coronary artery occlusion, ejection fraction decreased, nausea (What is nausea?), nocturia. During the same period patient was treated with AVANDIA (4 Mg, 2/d) (View Avandia Review and Avandia Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5482064-X | Palpitations
on Sep 27, 2007 Male patient from UNITED KINGDOM , 68 years of age, was treated with Pioglitazone (View Usage). Patient had the following side effects: palpitations. Pioglitazone dosage: . During the same period patient was treated with ASPRIN (ACETYLSALICYLIC ACID) (View Asprin (acetylsalicylic Acid) Review and Asprin (acetylsalicylic Acid) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ROSUVASTATIN (ROSUVASTATIN) (View Rosuvastatin (rosuvastatin) Review and Rosuvastatin (rosuvastatin) Label ).

5463798-X | Ankle Fracture, Fall, Joint Dislocation
on Sep 12, 2007 Female patient from UNITED STATES , 53 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: ankle fracture, fall (What is fall?), joint dislocation. Pioglitazone dosage: Per Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), BUTALBITAL/CAFFEINE/PARACETAMOL (CAFFEINE, BUTALBITAL, PARACETAMOL) (View Butalbital/caffeine/paracetamol (caffeine, Butalbital, Paracetamol) Review and Butalbital/caffeine/paracetamol (caffeine, Butalbital, Paracetamol) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), DIPHENHYDRAMINE HYDROCHLORIDE/PARACETAMOL/PESUDOEPHEDRINE HYDROCHLORID (View Diphenhydramine Hydrochloride/paracetamol/pesudoephedrine Hydrochlorid Review and Diphenhydramine Hydrochloride/paracetamol/pesudoephedrine Hydrochlorid Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

5453475-3 | Ankle Fracture, Fall, Fibula Fracture, Joint Dislocation
Patient was taking Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, fall (What is fall?), fibula fracture, joint dislocation on Sep 03, 2007 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with type 2 diabetes mellitus and. Pioglitazone dosage: Per Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), BUTABITAL/CAFFEINE/PARACETAMOL (CAFFEINE, BUTALBITAL, PARACETAMOL) (View Butabital/caffeine/paracetamol (caffeine, Butalbital, Paracetamol) Review and Butabital/caffeine/paracetamol (caffeine, Butalbital, Paracetamol) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), DIPHENHYDRAMINE HYDROCHLORIDE/PARACETAMOL/PSEUDOEPHEDRINE HYDROCHLORID (View Diphenhydramine Hydrochloride/paracetamol/pseudoephedrine Hydrochlorid Review and Diphenhydramine Hydrochloride/paracetamol/pseudoephedrine Hydrochlorid Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

5393783-8 | Cardiac Failure Congestive, Condition Aggravated
Adverse event was reported on Jul 19, 2007 by a Female patient taking Pioglitazone (View Usage) (Dosage: 15mg Daily Po) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: cardiac failure congestive, condition aggravated. Patient was hospitalized.

5378370-X | Dehydration, Hyperglycaemia, Hypokalaemia, Loss Of Consciousness, Urinary Tract Infection
on Jul 02, 2007 Female patient from UNITED STATES , 36 years of age, weighting 260.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Pioglitazone (View Usage). After Pioglitazone was administered, patient had the following side effects: dehydration, hyperglycaemia, hypokalaemia, loss of consciousness, urinary tract infection (What is urinary tract infection?). Pioglitazone dosage: 2 Tablets Qd Po. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5371416-4 | Fall, Fibula Fracture
on Jun 13, 2007 Female patient from UNITED STATES , 70 years of age, weighting 222.0 lb, was diagnosed with cerebrovascular accident prophylaxis, cardiac disorder and was treated with Pioglitazone (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), fibula fracture. Pioglitazone dosage: 45 Mg, 1 In 1 D, Per Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PROCARDIA XL (View Procardia Xl Review and Procardia Xl Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PROTONIX (View Protonix Review and Protonix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

5188091-4 | Fluid Retention
Patient was taking Pioglitazone (View Usage). Patient had the following side effects: fluid retention on Dec 14, 2006 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 142.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and. Pioglitazone dosage: 30 Mg Po Qd. During the same period patient was treated with VIT B12 (View Vit B12 Review and Vit B12 Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).